Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 324

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 324
---
 of Nasdaq and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be composed solely of independent directors. Subject to any applicable phase-in rules and a limited exception, the rules of Nasdaq require that the compensation committee of a listed company be comprised solely of independent directors.

#### Audit Committee
We have established an audit committee of the Iris Board. Messrs. Fernandez, Peretz and Shah serve as members of our audit committee, and Mr. Peretz chairs the audit committee. All members of our audit committee are independent of and unaffiliated with our sponsor and our underwriters. Each member of the audit committee is financially literate and the Iris Board has determined that Richard Peretz qualifies as an “audit committee financial expert” as defined in applicable SEC rules and has accounting or related financial management expertise. The audit committee is responsible for:

•

the integrity of the financial statements and other financial information provided by Iris to its stockholders, the public, any stock exchange and others;

•

Iris’s compliance with legal and regulatory requirements;

•

the qualifications and independence of Iris’s independent auditor;

•

the performance of Iris’s internal audit function and its system of internal controls and independent auditor; and

•

such other matters as are assigned to the audit committee by the Iris Board pursuant to its charter or as mandated under applicable laws, rules and regulations (including the Exchange Act).

#### Compensation Committee
The members of Iris’s compensation committee are Messrs. Fernandez, Peretz and Shah. Mr. Shah serves as chairman of the compensation committee. Under Nasdaq listing standards and applicable SEC rules, Iris is required to have a compensation committee comprised entirely of independent directors. Messrs. Fernandez, Peretz and Shah are independent.

Iris has adopted a compensation committee charter, which details the principal functions of the compensation committee, including:

•

reviewing and approving on an annual basis the corporate goals and objectives relevant to Iris’s Chief Executive Officer’s compensation evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of Iris’s Chief Executive Officer based on such evaluation;

•

reviewing and making recommendations to the Iris Board with respect to the compensation, and any incentive compensation and equity based plans that are subject to Iris Board approval of all of Iris’s other officers;

•

reviewing Iris’s executive compensation policies and plans;

•

implementing and administering Iris’s incentive compensation equity-based remuneration plans;

•

assisting management in complying with Iris’s proxy statement and annual